Skip to main content

Table 2 MIC values for common clinical antibiotics against PAHM4 and PAO1

From: Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains

Class

Antibiotic

MIC μg/ml for PAO1

MIC μg/ml for HM4

Penicillins

Piperacillin

4 (S)

>256 (R)

 

Piperacillin-Tazobactam

2 (S)

>256 (R)

 

Carbenicillin

32

64

Cephalosporins

Ceftazidime

1 (S)

16 (I)

 

Cefepime

1 (S)

6 (S)

 

Cefotaxime

8

>256

 

Ceftolozane

0.25

1

Monobactam

Aztreonam

2 (S)

8 (S)

Carbapenems

Imipenem

1.5 (S)

1.5 (S)

 

Meropenem

0.38 (S)

0.19 (S)

Quinolones

Ciprofloxacin

0.125 (S)

2 (I)

Aminoglycoside

Amikacin

4 (S)

96 (R)

 

Gentamicin

2 (S)

32 (R)

 

Tobramycin

1.5 (S)

4 (S)

Polymyxin

Colistin

2 (S)

0.19 (S)

Tetracycline

Tetracycline

16

4

Macrolide

Azithromycin

64

16

  1. Absolute MIC values and, when available, CLSI clinical categories (S: susceptible, I: intermediate, R: resistant) are indicated